US 10174098
Anti-human papillomavirus 16 E7 T cell receptors
granted A61KA61K38/00A61K38/1774
Quick answer
US patent 10174098 (Anti-human papillomavirus 16 E7 T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K38/00, A61K38/1774, A61P, A61P1/00